NCH Life Sciences is the leader in active probiotic technologies. Probiotics are live microorganisms that confer health benefits when consumed. We achieve digestive and environmental balance in applications including aquaculture, plants, poultry, swine, and human health. We are committed to helping our customers increase digestive health through state-of-the-art solutions, patented technologies, and forward-thinking research and development.
Our mission is to develop probiotic solutions that produce measurable improvements in digestive health.
There are many forms of probiotics on the market today. A large majority of them use live, active bacteria such as Lactobacillus and Bifidobacterium. These bacteria have no dormant state and are usually freeze-dried and desiccated for shelf-stability. As a result, they are sick and are sensitive to stomach acid. Consequently, many of them die before reaching the intestines. The cells that do survive have difficulty recovering and studies have shown that they have very little effect during their passage through the gut.
NCH Life Sciences probiotics contain Bacillus bacteria. Bacillus species have the unique ability to convert into a stable, dormant state called a spore. Spores are ideal for use in probiotics because they are resistant to harsh conditions like temperature and pH extremes. However, in order for spore-based probiotics to have an effect, the spores must first germinate and become active in the digestive tract. That is where our patent-pending ACTPRO™ technology comes in. This technology increases the germination rate of spores to over 95% for unparalleled performance. Spores are protected through the stomach and germinate once they reach a more hospitable environment in the upper intestine.
The patent-pending ACTPRO™ technology in our ECOcharger™ 1000 unit is revolutionizing the probiotics industry. This fully automated system requires no hands-on time from the user and doses Bacillus probiotic strains that have been specifically selected for proven gastrointestinal development. Our liquid formulation ensures consistent dosing and eliminates settling and separation found in powdered probiotics.
Some of the benefits we have seen in chickens include increased egg production, Salmonella reduction, feed efficiency improvements, and mortality reduction. All of this results in increased profits for our customers.
For more information, visit us at nchlifesciences.com or contact us at LifeSciences@nch.com
NCH Life Sciences, LLC is a wholly owned subsidiary of NCH Corporation.